HARBIN GLORIA PHARMACEUTICALS Co., LTD

SZSE:002437 Stock Report

Market Cap: CN¥5.7b

HARBIN GLORIA PHARMACEUTICALS Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 002437?
Owner TypeNumber of SharesOwnership Percentage
Private Companies99,682,7224.37%
Individual Insiders169,631,5117.44%
Institutions333,420,85014.6%
General Public1,677,014,86773.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 26.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.11%
Shanghai Fangyuan Dachuang Investment Partnership Enterprise (Limited Partnership)
116,406,600CN¥292.2m19.1%39.11%
4.85%
Zhenyu Shen
110,490,000CN¥277.3m0%no data
4.77%
Shanghai Guotai Junan Securities Asset Management Co., Ltd.
108,792,000CN¥273.1m0%0.83%
4.37%
Yu Heng International Investments Corporation
99,682,722CN¥250.2m0%no data
2.76%
Eastern Spring (Tianjin) Equity Investment Fund Management Co., Ltd.
62,864,267CN¥157.8m-42.7%41.15%
1.78%
Jianghai Securities Co., Ltd., Asset Management Arm
40,482,483CN¥101.6m0%36.19%
0.96%
Jin Hu
21,980,000CN¥55.2m0%no data
0.96%
Leifeng Guo
21,980,000CN¥55.2m0%no data
0.39%
Dongxu Wang
9,000,000CN¥22.6m-2.28%no data
0.1%
Xiaohang Wang
2,350,000CN¥5.9m0%no data
0.1%
Runbao Li
2,350,000CN¥5.9m0%no data
0.078%
Dimensional Fund Advisors LP
1,783,900CN¥4.5m260%no data
0.056%
SWS MU Fund Management Co., Ltd.
1,277,800CN¥3.2m0%0.01%
0.046%
Yueyin Liu
1,038,475CN¥2.6m0%no data
0.02%
Harvest Fund Management Co. Ltd.
450,000CN¥1.1m0%no data
0.016%
Xiuqiang Diao
360,936CN¥905.8k0%no data
0.014%
State Street Global Advisors, Inc.
312,800CN¥785.1k-1.64%no data
0.013%
Xin Yuan Asset Management Company
290,900CN¥730.1k0%0.04%
0.01%
China Southern Asset Management Co., Ltd.
230,700CN¥579.1k0%no data
0.0077%
Huatai-PineBridge Fund Management Co., Ltd.
176,100CN¥441.8k0%no data
0.0048%
E Fund Management Co., Ltd.
109,000CN¥273.5k0%no data
0.004%
Broad Asset Management Co., Ltd
90,500CN¥227.2k0%no data
0.0036%
Jiafeng Zang
82,100CN¥206.0k0%no data
0.0022%
Golden Trust SinoPac Fund Management Co., Ltd.
49,300CN¥123.6k0%no data
0.0018%
China Universal Asset Management Company Ltd.
41,800CN¥104.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/25 07:01
End of Day Share Price 2025/01/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HARBIN GLORIA PHARMACEUTICALS Co., LTD is covered by 13 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yalei YanBohai Securities Co., Ltd.
Shuchang LiuChangjiang Securities Co. LTD.
Shanshan LiChina Merchants Securities Co. Ltd.